Hence, ITGB6 represents a potential target, which may be exploited for clinical tumor imaging, therapy, theranostics, and as a prognostic marker, potentially resulting in an earlier diagnosis and intervention [19, 26–29]. This evidence concerns the gene ITGB6 and neoplasm.